In detail, patients with PACS are exposed to high systemic levels of sarcopenic cytokines, namely IL-6 and TNFα, which reduce the number and functionality of mitochondria in skeletal muscle cells, inducing sarcopenia [111]. Here, IL6 is linked to sarcopenia.